DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Dauricine

Dauricine

  • United States Patent (19) 11 Patent Number: 5,627,195 Hu 45 Date of Patent: May 6, 1997

    United States Patent (19) 11 Patent Number: 5,627,195 Hu 45 Date of Patent: May 6, 1997

  • Analytical Reference Standards

    Analytical Reference Standards

  • Accepted Version

    Accepted Version

  • Methoxy-3-Veratryl-5,6-Dihydrobenzoglyoxalocoline T

    Methoxy-3-Veratryl-5,6-Dihydrobenzoglyoxalocoline T

  • UC Riverside UC Riverside Previously Published Works

    UC Riverside UC Riverside Previously Published Works

  • (12) United States Patent (10) Patent No.: US 6,949,521 B2 Chu Et Al

    (12) United States Patent (10) Patent No.: US 6,949,521 B2 Chu Et Al

  • Novel Chemical Tools for the Modulation of Two Pore Channel 2

    Novel Chemical Tools for the Modulation of Two Pore Channel 2

  • Prevention and Reversal of Alzheimer's Disease Copyright © 2017 Ronald N

    Prevention and Reversal of Alzheimer's Disease Copyright © 2017 Ronald N

  • Permanently Charged Sodium and Calcium Channel Blockers As Anti-Inflammatory Agents

    Permanently Charged Sodium and Calcium Channel Blockers As Anti-Inflammatory Agents

  • Namenverzeichnis. Index of Names. Index Des Auteurs

    Namenverzeichnis. Index of Names. Index Des Auteurs

  • (12) Patent Application Publication (10) Pub. No.: US 2012/0172429 A1 Woolf Et Al

    (12) Patent Application Publication (10) Pub. No.: US 2012/0172429 A1 Woolf Et Al

  • Recent Progress on Biological Activity of Amaryllidaceae and Further Isoquinoline Alkaloids in Connection with Alzheimer’S Disease

    Recent Progress on Biological Activity of Amaryllidaceae and Further Isoquinoline Alkaloids in Connection with Alzheimer’S Disease

  • Osteoarthritis Guideline Appendix 4 – Search Strategies

    Osteoarthritis Guideline Appendix 4 – Search Strategies

  • Obesity Small Molecules

    Obesity Small Molecules

  • JIA Guideline Appendix 4

    JIA Guideline Appendix 4

  • Supplementary Materials

    Supplementary Materials

  • JIA Uveitis Guideline Appendix 3

    JIA Uveitis Guideline Appendix 3

  • Analytical Reference Standards 2012 800/654-1458 | 512/238-9129 | | 512/238-9129

    Analytical Reference Standards 2012 800/654-1458 | 512/238-9129 | | 512/238-9129

Top View
  • The 2016 “Research on Drug Evidence” Report [From the 18Th ICPO / INTERPOL Forensic Science Symposium]
  • Effectiveness of Sugammadex for Cerebral Ischemia/Reperfusion Injury
  • Metabolomics Identifies a Biomarker Revealing in Vivo Loss of Functional ß-Cell Mass
  • Alkaloids, Terpenes, Polyphenols, And
  • Metal Ion-Responsive Nanocarrier Derived from Phosphonated Calix[4]


© 2024 Docslib.org    Feedback